These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 26971586)

  • 61. Virulence properties of uropathogenic Escherichia coli isolated from children with urinary tract infection in Korea.
    Kim DH; Subhadra B; Kang HY; Woo K; Kim J; Son YJ; Sohn KM; Kim HJ; Han K; Oh MH; Choi CH
    Genes Genomics; 2018 Jun; 40(6):625-634. PubMed ID: 29892947
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Detection of AmpC β-lactamase and adherence factors in uropathogenic Escherichia coli isolated from aged patients.
    Singh SK; Seema K; Gupta M
    Microb Pathog; 2016 Nov; 100():293-298. PubMed ID: 27744103
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Intestinal Bacteriophage Therapy: Looking for Optimal Efficacy.
    Javaudin F; Latour C; Debarbieux L; Lamy-Besnier Q
    Clin Microbiol Rev; 2021 Dec; 34(4):e0013621. PubMed ID: 34668734
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Managing urinary tract infections through phage therapy: a novel approach.
    Malik S; Sidhu PK; Rana JS; Nehra K
    Folia Microbiol (Praha); 2020 Apr; 65(2):217-231. PubMed ID: 31494814
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Oral application of Escherichia coli bacteriophage: safety tests in healthy and diarrheal children from Bangladesh.
    Sarker SA; Berger B; Deng Y; Kieser S; Foata F; Moine D; Descombes P; Sultana S; Huq S; Bardhan PK; Vuillet V; Praplan F; Brüssow H
    Environ Microbiol; 2017 Jan; 19(1):237-250. PubMed ID: 27750388
    [TBL] [Abstract][Full Text] [Related]  

  • 66. PHAGE Study: Effects of Supplemental Bacteriophage Intake on Inflammation and Gut Microbiota in Healthy Adults.
    Febvre HP; Rao S; Gindin M; Goodwin NDM; Finer E; Vivanco JS; Lu S; Manter DK; Wallace TC; Weir TL
    Nutrients; 2019 Mar; 11(3):. PubMed ID: 30897686
    [TBL] [Abstract][Full Text] [Related]  

  • 67. In vitro activity of a combination of bacteriophages and antimicrobial plant extracts.
    Pimchan T; Cooper CJ; Eumkeb G; Nilsson AS
    Lett Appl Microbiol; 2018 Mar; 66(3):182-187. PubMed ID: 29266343
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Phage therapy: the Escherichia coli experience.
    Brüssow H
    Microbiology (Reading); 2005 Jul; 151(Pt 7):2133-2140. PubMed ID: 16000704
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Alternative Therapeutic Options to Antibiotics for the Treatment of Urinary Tract Infections.
    Loubet P; Ranfaing J; Dinh A; Dunyach-Remy C; Bernard L; Bruyère F; Lavigne JP; Sotto A
    Front Microbiol; 2020; 11():1509. PubMed ID: 32719668
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Phage Targeting Neonatal Meningitis
    Antoine C; Laforêt F; Goya-Jorge E; Gonza I; Lebrun S; Douny C; Duprez JN; Fall A; Taminiau B; Scippo ML; Daube G; Thiry D; Delcenserie V
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445758
    [No Abstract]   [Full Text] [Related]  

  • 71. Bacteriophages allow selective depletion of gut bacteria to produce a targeted-bacterium-depleted mouse model.
    Li Y; Zhu F; Li Y; Pan S; Wang H; Yang Z; Wang Z; Hu Z; Yu J; Barritt JD; Li T; Liu X; Wang Y; Ma X; Liu B
    Cell Rep Methods; 2022 Nov; 2(11):100324. PubMed ID: 36452872
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Use of a Chicken Embryo Lethality Assay to Assess the Efficacy of Phage Therapy.
    Trotereau A; Schouler C
    Methods Mol Biol; 2019; 1898():199-205. PubMed ID: 30570735
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Longitudinal multi-omics analyses link gut microbiome dysbiosis with recurrent urinary tract infections in women.
    Worby CJ; Schreiber HL; Straub TJ; van Dijk LR; Bronson RA; Olson BS; Pinkner JS; Obernuefemann CLP; Muñoz VL; Paharik AE; Azimzadeh PN; Walker BJ; Desjardins CA; Chou WC; Bergeron K; Chapman SB; Klim A; Manson AL; Hannan TJ; Hooton TM; Kau AL; Lai HH; Dodson KW; Hultgren SJ; Earl AM
    Nat Microbiol; 2022 May; 7(5):630-639. PubMed ID: 35505248
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Examining the Effects of an Anti-Salmonella Bacteriophage Preparation, BAFASAL
    Mayne J; Zhang X; Butcher J; Walker K; Ning Z; Wójcik E; Dastych J; Stintzi A; Figeys D
    Viruses; 2021 Aug; 13(9):. PubMed ID: 34578313
    [No Abstract]   [Full Text] [Related]  

  • 75. The Battle Within: Interactions of Bacteriophages and Bacteria in the Gastrointestinal Tract.
    De Sordi L; Lourenço M; Debarbieux L
    Cell Host Microbe; 2019 Feb; 25(2):210-218. PubMed ID: 30763535
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Bacteriophages as potential new mammalian pathogens.
    Tetz GV; Ruggles KV; Zhou H; Heguy A; Tsirigos A; Tetz V
    Sci Rep; 2017 Aug; 7(1):7043. PubMed ID: 28765534
    [TBL] [Abstract][Full Text] [Related]  

  • 77. In situ reprogramming of gut bacteria by oral delivery.
    Hsu BB; Plant IN; Lyon L; Anastassacos FM; Way JC; Silver PA
    Nat Commun; 2020 Oct; 11(1):5030. PubMed ID: 33024097
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Bacteriocins and Bacteriophages: Therapeutic Weapons for Gastrointestinal Diseases?
    Lopetuso LR; Giorgio ME; Saviano A; Scaldaferri F; Gasbarrini A; Cammarota G
    Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30621339
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Bacteriophages: Uncharacterized and Dynamic Regulators of the Immune System.
    Sinha A; Maurice CF
    Mediators Inflamm; 2019; 2019():3730519. PubMed ID: 31582898
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Bacteriophages as Potential Treatment for Urinary Tract Infections.
    Sybesma W; Zbinden R; Chanishvili N; Kutateladze M; Chkhotua A; Ujmajuridze A; Mehnert U; Kessler TM
    Front Microbiol; 2016; 7():465. PubMed ID: 27148173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.